This inventor holds 2 USPTO granted patents. Top assignee: Neogene Therapeutics B.v.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Gavin M Bendle: Innovator in Genetic Engineering
Introduction
Gavin M Bendle is a prominent inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of genetic engineering, particularly in the development of advanced T cell therapies. His innovative work has the potential to impact various medical applications.
Latest Patents
Gavin M Bendle holds a patent titled "Methods to Enrich Genetically Engineered T Cells." This patent represents a crucial advancement in the enhancement of T cell therapies, which are vital for treating various diseases, including cancer. He has 1 patent to his name, showcasing his commitment to innovation in this specialized field.
Career Highlights
Bendle is currently employed at Neogene Therapeutics B.V., a company dedicated to developing next-generation T cell therapies. His role at Neogene Therapeutics allows him to work on cutting-edge research and contribute to the advancement of genetic engineering technologies.
Collaborations
Throughout his career, Gavin has collaborated with notable colleagues, including Jeroen WJ Van Heijst and Xiangjun Kong. These collaborations have fostered a productive environment for innovation and research in the field of genetic engineering.
Conclusion
Gavin M Bendle is a key figure in the realm of genetic engineering, with a focus on enhancing T cell therapies. His contributions through patents and collaborations highlight his dedication to advancing medical science.